WEST PALM BEACH, FL, April 16, 2025 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company”) announces that it has filed its Annual Report on Form 10-K on April 15, 2025.

A recent selloff of Neurocrine Biosciences stock feels unwarranted and may have created a contrarian buy opportunity. Learn ...

We recently published a list of Jim Cramer is Bullish on These 10 Stocks. In this article, we are going to take a look at ...

A mighty gust of wind on a dreary morning only lifted the sail of the freshly cut ribbon, on Community Action House’s new set ...

A physician survey for Neurocrine Biosciences Inc's NBIX +1.72% Get Free Report Crenessity suggests "strong uptake across all patient segments," according to Needham. The Neurocrine Biosciences ...

In a report released today, Erin Wright from Morgan Stanley maintained a Buy rating on Cardinal Health (CAH – Research Report), with a price ...

The Zacks Medical - Dental Supplies industry in the Medical sector has a robust demand for dental services, driven by patient ...

When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could ...

Cardinal Health Inc. closed 5.54% short of its 52-week high of $139.50, which the company achieved on April 3rd.

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

A study conducted by the Maine Hospital Association reveals larger hospitals in the state are poor, heavily in debt and ...

Many hospitals in Maine, particularly larger ones, are heavily in debt, poor and working out of older facilities, according ...